Emerald Mutual Fund Advisers Trust’s Neos Therapeutics, Inc NEOS Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-402,968	Closed	-$4.35M	–	289
2016 Q1	$4.35M	Sell	402,968 -9,090	-2%	-$95.9K	0.24%	123
2015 Q4	$5.9M	Buy	412,058 +80,916	+24%	+$1.22M	0.31%	104
2015 Q3	$6.96M	Buy	+331,142	New	+$7.3M	0.46%	85

Other funds holding NEOS

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's NEOS Position: Q2 2016 in Review

Emerald Mutual Fund Advisers Trust sold out of Neos Therapeutics, Inc (NEOS) in Q2 2016, closing a stake of 402,968 shares — an estimated $4.35M sold.

Emerald Mutual Fund Advisers Trust first reported a position in NEOS in Q3 2015 and held it in 3 quarters. The position peaked at $6.96M in Q3 2015. 46 funds tracked by Wall St. Rank hold NEOS as of Q2 2016.

Emerald Mutual Fund Advisers Trust reported no remaining Neos Therapeutics, Inc position as of Q2 2016 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 402,968 Neos Therapeutics, Inc shares in Q2 2016, an estimated $4.35M.
Emerald Mutual Fund Advisers Trust first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 3 quarters.
Emerald Mutual Fund Advisers Trust's Neos Therapeutics, Inc position peaked at $6.96M in Q3 2015.
46 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2016.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2016, filed 28 Jul 2016.